Cover Image
市場調查報告書

膽囊癌 (GBC) 的預測:主要18市場

Gallbladder Cancer Forecast In 18 Major Markets 2015 -2025

出版商 Black Swan Analysis 商品編碼 342578
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
膽囊癌 (GBC) 的預測:主要18市場 Gallbladder Cancer Forecast In 18 Major Markets 2015 -2025
出版日期: 2015年10月27日 內容資訊: 英文 62 Pages
簡介

膽囊癌 (GBC) ,不僅主要在膽囊本身發生,也包含肝外膽管,及乏特氏壺腹,未指定的膽管腫瘤等。

本報告提供主要18個市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本、加拿大、澳洲、印度、墨西哥、土耳其、韓國、沙烏地阿拉伯、阿根廷、俄羅斯、中國) 的膽囊癌 (GBC) 依照目前患者數 (性別、年齡世代) 的調查分析、目前盛行率,加上疾病概要、危險因素、疾病診斷預後、主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:地區/各民族

疾病預後與臨床過程

疾病相關的主要併發症/特徵

定量化患者數的手法

膽囊癌 (GBC) 的盛行率top line

膽囊癌 (GBC) 的病期和場所

  • 膽囊癌 (GBC) 的AJCC診斷
  • 膽囊癌 (GBC) 之癌細胞的組織病理學
  • 膽囊癌 (GBC) 的腫瘤場所

膽囊癌 (GBC) 的相關症狀

  • 膽囊癌 (GBC) 患者的BMI情形
  • 與膽囊癌 (GBC) 關聯的疼痛狀態
  • 膽囊癌 (GBC) 的遺傳基因的過剩表現

簡稱

相關出版

以線上患者為基礎的資料庫

以患者為基礎的產品

線上的價格資料和平台

參考文件

附錄

目錄
Product Code: GALL0010915

Gallbladder Cancer (GBC) primarily occurs in the gallbladder itself, but also includes the extrahepatic bile duct, Ampulla of Vater and other non-specified biliary duct tumours. It is currently the most common malignant tumour of the biliary tract worldwide, with a very low survival rate. There are currently no known causes for GBC at this point in time.

This report provides the current incidence population for GBC across 18 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, Canada, Australia, India, Mexico, Turkey, South Africa, Saudi Arabia, Argentina, Russia and China) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, locations and histopathology of GBC tumours. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of GBC have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for GBC include:

  • Obesity
  • Chronic cholecystitis
  • Choleithiasis
  • Gallstones
  • Diabetes

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global GBC's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of GBC and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on GBC's prevalent population.
  • Examination of the incidence of the different causative gene mutations for GBC.
  • Identify sub-populations within GBC which require treatment.
  • Gain an understanding of the specific markets that have the largest number of GBC patients.

Coverage

  • U.S.
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain
  • Japan
  • U.K.
  • China
  • India
  • Turkey
  • Canada
  • Australia
  • Netherland
  • Argentine
  • Russia
  • Korea
  • Mexico

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key Co-morbid Conditions/ Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Gallbladder Cancer Incidence
  • Stages and Location of Gallbladder Cancer
    • AJCC Staging of Gallbladder Cancer
    • Histopathology of Tumour Cells in Gallbladder Cancer
    • Gallbladder Cancer Tumour Location
  • Associated Conditions of Gallbladder Cancer
    • BMI Status of Gallbladder Cancer Patients
    • Pain-related Conditions Associated with Gallbladder Cancer
    • Gene Over-expression in Gallbladder Cancer
  • Abbreviations used in the Report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Figures

  • Gallbladder Cancer Incidence Rates for 2015

List of Tables

  • AJCC Tumour Staging Classification for Gallbladder Cancer
  • Incidence of Gallbladder Cancer, total (000s)
  • Incidence of Gallbladder Cancer, males (000s)
  • Incidence of Gallbladder Cancer, females (000s)
  • AJCC Stages of Gallbladder Cancer patients, total (000s)
  • Major Histopathological type in Gallbladder Cancer, total (000s)
  • Tumour location in Gallbladder Cancer patients, total (000s)
  • BMI of Gallbladder Cancer patients, total (000s)
  • Gallstones in Gallbladder Cancer patients, total (000s)
  • EGFR in Gallbladder Cancer patients, total (000s)
  • p53 in Gallbladder Cancer patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • USA Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • France Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • France Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Germany Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Germany Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Italy Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Italy Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Spain Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Spain Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • United Kingdom Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • United Kingdom Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Brazil Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Brazil Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Japan Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Japan Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • India Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • India Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Australia Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Australia Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Canada Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Canada Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Mexico Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Mexico Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Turkey Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Turkey Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • South Africa Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • South Africa Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Saudi Arabia Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Saudi Arabia Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Argentina Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Argentina Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • Russia Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • Russia Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
  • China Incidence of Gallbladder Cancer by 5-yr age cohort, males (000s)
  • China Incidence of Gallbladder Cancer by 5-yr age cohort, females (000s)
Back to Top